Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
885 Queen Anne Rd
Teaneck, NJ 07666Phone+1 201-723-0278Fax+1 201-862-1008
Education & Training
NYU Grossman School of MedicineResidency, Pediatrics, 1970 - 1973- New York University School of MedicineClass of 1970
Certifications & Licensure
VA State Medical License Current
NY State Medical License 1971 - 2026
NJ State Medical License 1981 - 2025- American Board of Pediatrics Pediatrics
Clinical Trials
- High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2014 Nov 26
Publications & Presentations
PubMed
- 250 citationsComparison of RNA-seq and microarray-based models for clinical endpoint prediction.Wenqian Zhang, Ying Yu, Falk Hertwig, Jean Thierry-Mieg, Wenwei Zhang
Genome Biology. 2015-06-25 - 108 citationsFirst-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N. Stein, Joseph R. Bertino, Howard L. Kaufman, Tina M. Mayer, Rebecca A. Moss
Clinical Cancer Research. 2017-08-01 - 105 citationsDiscovery and clinical introduction of first-in-class imipridone ONC201Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa
Oncotarget. 2016-09-01
Press Mentions
ImmVira Appoints Howard L. Kaufman, M.D. As Consulting Medical AdvisorAugust 24th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
